Epidermal Growth Factors (EGF) Market Propelled by Increasing Geriatric Population Facing Age-Related Skin Conditions


 EGF are signaling protein involved in regulating cell growth, proliferation and differentiation. EGF improves wound healing process by stimulating re-epithelialization and collagen deposition which increases skin thickness and tensile strength. EGF products are widely used in cosmetic industry for anti-aging creams and other dermal products to treat wrinkles, blemishes and other signs of aging.

The global Epidermal Growth Factors (EGF) Market is estimated to be valued at US$ 1,349.6 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Key Trends: Growth Accelerated by Increasing Demand in Cosmetic Industry

The cosmetic industry has witnessed robust growth over the past few years as customers are increasingly adopting anti-aging products to reduce signs of aging such as wrinkles, fine lines and aged skin. Epidermal growth factors help stimulate collagen production and regenerate cells, thereby helping effectively reduce wrinkles and diminish other aging effects. They help plump and tighten loose skin, minimizing the appearance of fine lines and wrinkles. EGF products claim to enhance skin texture and firmness. Many leading cosmetic brands have introduced anti-aging serums and creams containing epidermal growth factors to cater to the growing demand. The proliferation of online sales channels have further facilitated easy accessibility of such cosmetic products boosting the EGF market growth.

Segment Analysis
The global epidermal growth factors (EGF) market is dominated by the skin care segment. EGF are widely used in anti-aging creams and serums to stimulate collagen production and reduce the appearance of fine lines and wrinkles. Within the skin care segment, anti-aging products form the largest sub-segment as EGF are able to rejuvenate aging skin and help improve elasticity, tone and texture.

Key Takeaways
The global epidermal growth factors (EGF) market is expected to witness high growth over the forecast period of 2023 to 2030.

Regionally, North America is currently the dominant region for the EGF market. Higher consumer awareness regarding anti-aging skin care products and greater adoption of premium cosmetic products is driving the market in the region. Asia Pacific is expected to be the fastest growing market during the forecast period owing to increasing disposable incomes, rising middle class population and growing consciousness about health and wellness products.

Key players operating in the epidermal growth factors (EGF) market are Radiant Inc., Pavay, BIO-FD&C Co. Ltd., BIOEFFECT, LipoTrue, S.L., and Ytkangdaer. Radiant Inc. is a major player offering a wide range of EGF products for skin care applications. The company has a strong distribution network across major markets. BIO-FD&C Co. Ltd. specializes in biotechnology and pharmaceutical products. It is one of the leading suppliers of EGF to skin care brands across Asia. LipoTrue, S.L. is a Spanish company manufacturing natural anti-aging cosmetic ingredients including EGF. It focuses on supplying custom EGF formulations to regional skin care companies.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more